CFDB - Cystic Fibrosis DataBase

All subcategories » trial from www.clinicaltrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF - PHASE2 - RECRUITING

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2024
  • Kors van der Ent

Bionic Pancreas in CFRD - PHASE3 - NOT_YET_RECRUITING

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2024
  • Jaeb Center for Health Research

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis - Phase 1|Phase 2 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2023
  • Cystetic Medicines, Inc.|DevPro Biopharma

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis - - RECRUITING

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2024

Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study - - NOT_YET_RECRUITING

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2024

SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes - Phase 2|Phase 3 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2023
  • Amir Moheet|University of Minnesota

A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis - Phase 1|Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2023
  • Clarametyx Biosciences, Inc.

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™) - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2023
  • Boehringer Ingelheim

Estrogen Patches for Adolescent and Young Adult Women With Cystic Fibrosis - Phase 4 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2023
  • Johns Hopkins University|Cystic Fibrosis Foundation

Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • Aceragen